{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["amide", "aminoquinoline", "antimalarial", "antioxidant", "antiparasitic", "antiproliferative", "artemisinin", "chloroquine", "cinnamic", "ionic liquid", "primaquine", "repurposing", "rescuing"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31878190", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "02", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "24"}], "Language": ["eng"], "ELocationID": ["66", "10.3390/molecules25010066"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "24"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Cinnamic Acid Conjugates in the Rescuing and Repurposing of Classical Antimalarial Drugs.", "Abstract": {"AbstractText": ["Cinnamic acids are compounds of natural origin that can be found in many different parts of a wide panoply of plants, where they play the most diverse biological roles, often in a conjugated form. For a long time, this has been driving Medicinal Chemists towards the investigation of the therapeutic potential of natural, semi-synthetic, or fully synthetic cinnamic acid conjugates. These efforts have been steadily disclosing promising drug leads, but a wide chemical space remains that deserves to be further explored. Amongst different reported approaches, the combination or conjugation of cinnamic acids with known drugs has been addressed in an attempt to produce either synergistic or multi-target action. In this connection, the present review will focus on efforts of the past decade regarding conjugation with cinnamic acids as a tool for the rescuing or the repurposing of classical antimalarial drugs, and also on future perspectives in this particular field of research."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV-REQUIMTE, Departamento de Qu\u00edmica e Bioqu\u00edmica, Faculdade de Ci\u00eancias, Universidade do Porto, P-4169-007 Porto, Portugal."}], "LastName": "Silva", "ForeName": "Ana Teresa", "Initials": "AT"}, {"Identifier": ["0000-0001-9019-7334"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, P-4200-135 Porto, Portugal."}, {"Identifier": [], "Affiliation": "IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, P-4200-135 Porto, Portugal."}], "LastName": "Bento", "ForeName": "Clara M", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal."}], "LastName": "Pena", "ForeName": "Ana C", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal."}], "LastName": "Figueiredo", "ForeName": "Lu\u00edsa M", "Initials": "LM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ci\u00eancias Qu\u00edmicas e das Biomol\u00e9culas, Escola Superior de Sa\u00fade-Instituto Polit\u00e9cnico do Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida 400, P-4200-072 Porto, Portugal."}], "LastName": "Prud\u00eancio", "ForeName": "Cristina", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV-REQUIMTE, Departamento de Qu\u00edmica e Bioqu\u00edmica, Faculdade de Ci\u00eancias, Universidade do Porto, P-4169-007 Porto, Portugal."}], "LastName": "Aguiar", "ForeName": "Lu\u00edsa", "Initials": "L"}, {"Identifier": ["0000-0002-6087-1487"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, P-4200-135 Porto, Portugal."}, {"Identifier": [], "Affiliation": "IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, P-4200-135 Porto, Portugal."}], "LastName": "Silva", "ForeName": "T\u00e2nia", "Initials": "T"}, {"Identifier": ["0000-0002-1761-117X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV-REQUIMTE, Departamento de Qu\u00edmica e Bioqu\u00edmica, Faculdade de Ci\u00eancias, Universidade do Porto, P-4169-007 Porto, Portugal."}, {"Identifier": [], "Affiliation": "Ci\u00eancias Qu\u00edmicas e das Biomol\u00e9culas, Escola Superior de Sa\u00fade-Instituto Polit\u00e9cnico do Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida 400, P-4200-072 Porto, Portugal."}], "LastName": "Ferraz", "ForeName": "Ricardo", "Initials": "R"}, {"Identifier": ["0000-0001-7657-2118"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, P-4200-135 Porto, Portugal."}, {"Identifier": [], "Affiliation": "IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, P-4200-135 Porto, Portugal."}, {"Identifier": [], "Affiliation": "ICBAS-Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, P-4050-313 Porto, Portugal."}], "LastName": "Gomes", "ForeName": "Maria Salom\u00e9", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV-REQUIMTE, Departamento de Qu\u00edmica e Bioqu\u00edmica, Faculdade de Ci\u00eancias, Universidade do Porto, P-4169-007 Porto, Portugal."}], "LastName": "Teixeira", "ForeName": "C\u00e1tia", "Initials": "C"}, {"Identifier": ["0000-0002-6018-4724"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV-REQUIMTE, Departamento de Qu\u00edmica e Bioqu\u00edmica, Faculdade de Ci\u00eancias, Universidade do Porto, P-4169-007 Porto, Portugal."}], "LastName": "Gomes", "ForeName": "Paula", "Initials": "P"}], "GrantList": [{"GrantID": "UID/QUI/50006/2019", "Agency": "Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia", "Country": ""}, {"GrantID": "PTDC/BTM-SAL/29786/2017", "Agency": "Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Cinnamates"}, {"RegistryNumber": "0", "NameOfSubstance": "Ionic Liquids"}, {"RegistryNumber": "140-10-3", "NameOfSubstance": "cinnamic acid"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cinnamates"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ionic Liquids"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lee H.-G., Jo Y., Ameer K., Kwon J.-H. Optimization of green extraction methods for cinnamic acid and cinnamaldehyde from cinnamon (Cinnamomum cassia) by response surface methodology. Food Sci. Biotechnol. 2018;27:1607\u20131617. doi: 10.1007/s10068-018-0441-y.", "ArticleIdList": ["10.1007/s10068-018-0441-y", "PMC6233399", "30483424"]}, {"Citation": "Lingbeck J.M., O\u2019Bryan C.A., Martin E.M., Adams J.P., Crandall P.G. Sweetgum: An ancient source of beneficial compounds with modern benefits. Pharmacogn. Rev. 2015;9:1\u201311.", "ArticleIdList": ["PMC4441155", "26009686"]}, {"Citation": "Sharma P. Cinnamic acid derivatives: A new chapter of various pharmacological activities. J. Chem. Pharm. Res. 2011;3:403\u2013423."}, {"Citation": "Guzman J.D. Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules. 2014;19:19292\u201319349. doi: 10.3390/molecules191219292.", "ArticleIdList": ["10.3390/molecules191219292", "PMC6271800", "25429559"]}, {"Citation": "Tian Y., Liu W., Lu Y., Wang Y., Chen X., Bai S., Zhao Y., He T., Lao F., Shang Y., et al. Naturally occurring cinnamic acid sugar ester derivatives. Molecules. 2016;21:1402. doi: 10.3390/molecules21101402.", "ArticleIdList": ["10.3390/molecules21101402", "PMC6273327", "27783048"]}, {"Citation": "Salvador V.H., Lima R.B., dos Santos W.D., Soares A.R., Bohm P.A., Marchiosi R., Ferrarese Mde L., Ferrarese-Filho O. Cinnamic acid increases lignin production and inhibits soybean root growth. PLoS ONE. 2013;8:e69105. doi: 10.1371/journal.pone.0069105.", "ArticleIdList": ["10.1371/journal.pone.0069105", "PMC3724853", "23922685"]}, {"Citation": "Bia\u0142ecka-Florja\u0144czyk E., Fabiszewska A., Zieniuk B. Phenolic acids derivatives\u2014Biotechnological methods of synthesis and bioactivity. Curr. Pharm. Biotechnol. 2018;19:1098\u20131113. doi: 10.2174/1389201020666181217142051.", "ArticleIdList": ["10.2174/1389201020666181217142051", "30556498"]}, {"Citation": "Celentano A., Tran A., Testa C., Thayanantha K., Tan-Orders W., Tan S., Syamal M., McCullough M.J., Yap T. The protective effects of kava (Piper methysticum) constituents in cancers: A systematic review. J. Oral Pathol. Med. 2019;48:510\u2013529. doi: 10.1111/jop.12900.", "ArticleIdList": ["10.1111/jop.12900", "31172600"]}, {"Citation": "De P., Baltas M., Bedos-Belval F. Cinnamic acid derivatives as anticancer agents-a review. Curr. Med. Chem. 2011;18:1672\u20131703. doi: 10.2174/092986711795471347.", "ArticleIdList": ["10.2174/092986711795471347", "21434850"]}, {"Citation": "Liu L., Hudgins W.R., Shack S., Yin M.Q., Samid D. Cinnamic acid: A natural product with potential use in cancer intervention. Int. J. Cancer. 1995;62:345\u2013350. doi: 10.1002/ijc.2910620319.", "ArticleIdList": ["10.1002/ijc.2910620319", "7628877"]}, {"Citation": "Lu M., Li T., Wan J., Li X., Yuan L., Sun S. Antifungal effects of phytocompounds on candida species alone and in combination with fluconazole. Int. J. Antimicrob. Agents. 2017;49:125\u2013136. doi: 10.1016/j.ijantimicag.2016.10.021.", "ArticleIdList": ["10.1016/j.ijantimicag.2016.10.021", "28040409"]}, {"Citation": "Nimse S.B., Pal D., Mazumder A., Mazumder R. Synthesis of cinnamanilide derivatives and their antioxidant and antimicrobial activity. J. Chem. 2015;2015:208910. doi: 10.1155/2015/208910.", "ArticleIdList": ["10.1155/2015/208910"]}, {"Citation": "Pontiki E., Hadjipavlou-Litina D., Litinas K., Geromichalos G. Novel cinnamic acid derivatives as antioxidant and anticancer agents: Design, synthesis and modeling studies. Molecules. 2014;19:9655\u20139674. doi: 10.3390/molecules19079655.", "ArticleIdList": ["10.3390/molecules19079655", "PMC6270778", "25004073"]}, {"Citation": "Sova M. Antioxidant and antimicrobial activities of cinnamic acid derivatives. Mini Rev. Med. Chem. 2012;12:749\u2013767. doi: 10.2174/138955712801264792.", "ArticleIdList": ["10.2174/138955712801264792", "22512578"]}, {"Citation": "Jabir N.R., Khan F.R., Tabrez S. Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of alzheimer\u2019s disease. CNS Neurosci. Ther. 2018;24:753\u2013762. doi: 10.1111/cns.12971.", "ArticleIdList": ["10.1111/cns.12971", "PMC6489761", "29770579"]}, {"Citation": "Abdulwanis Mohamed Z., Mohamed Eliaser E., Mazzon E., Rollin P., Cheng Lian Ee G., Abdull Razis F.A. Neuroprotective potential of secondary metabolites from melicope lunu-ankenda (rutaceae) Molecules. 2019;24:3109. doi: 10.3390/molecules24173109.", "ArticleIdList": ["10.3390/molecules24173109", "PMC6749319", "31461914"]}, {"Citation": "Gunia-Krzyzak A., Panczyk K., Waszkielewicz A.M., Marona H. Cinnamamide derivatives for central and peripheral nervous system disorders\u2014A review of structure-activity relationships. ChemMedChem. 2015;10:1302\u20131325. doi: 10.1002/cmdc.201500153.", "ArticleIdList": ["10.1002/cmdc.201500153", "26083325"]}, {"Citation": "Priebe A., Hunke M., Tonello R., Sonawane Y., Berta T., Natarajan A., Bhuvanesh N., Pattabiraman M., Chandra S. Ferulic acid dimer as a non-opioid therapeutic for acute pain. J. Pain Res. 2018;11:1075\u20131085. doi: 10.2147/JPR.S161161.", "ArticleIdList": ["10.2147/JPR.S161161", "PMC5997134", "29922083"]}, {"Citation": "Pontiki E., Hadjipavlou-Litina D. Multi-target cinnamic acids for oxidative stress and inflammation: Design, synthesis, biological evaluation and modeling studies. Molecules. 2018;24:12. doi: 10.3390/molecules24010012.", "ArticleIdList": ["10.3390/molecules24010012", "PMC6337588", "30577525"]}, {"Citation": "Vinayagam R., Jayachandran M., Xu B. Antidiabetic effects of simple phenolic acids: A comprehensive review. Phytother. Res. 2016;30:184\u2013199. doi: 10.1002/ptr.5528.", "ArticleIdList": ["10.1002/ptr.5528", "26634804"]}, {"Citation": "Zhu R., Liu H., Liu C., Wang L., Ma R., Chen B., Li L., Niu J., Fu M., Zhang D., et al. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacol. Res. 2017;122:78\u201389. doi: 10.1016/j.phrs.2017.05.019.", "ArticleIdList": ["10.1016/j.phrs.2017.05.019", "28559210"]}, {"Citation": "Amano R., Yamashita A., Kasai H., Hori T., Miyasato S., Saito S., Yokoe H., Takahashi K., Tanaka T., Otoguro T., et al. Cinnamic acid derivatives inhibit hepatitis c virus replication via the induction of oxidative stress. Antivir. Res. 2017;145:123\u2013130. doi: 10.1016/j.antiviral.2017.07.018.", "ArticleIdList": ["10.1016/j.antiviral.2017.07.018", "28780423"]}, {"Citation": "De P., De K., Veau D., Bedos-Belval F., Chassaing S., Baltas M. Recent advances in the development of cinnamic-like derivatives as antituberculosis agents. Expert Opin. Ther. Pat. 2012;22:155\u2013168. doi: 10.1517/13543776.2012.661717.", "ArticleIdList": ["10.1517/13543776.2012.661717", "22329571"]}, {"Citation": "De P., Koumba Yoya G., Constant P., Bedos-Belval F., Duran H., Saffon N., Daffe M., Baltas M. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents. J. Med. Chem. 2011;54:1449\u20131461. doi: 10.1021/jm101510d.", "ArticleIdList": ["10.1021/jm101510d", "21309577"]}, {"Citation": "Kumar V., Patel S., Jain R. New structural classes of antituberculosis agents. Med. Res. Rev. 2018;38:684\u2013740. doi: 10.1002/med.21454.", "ArticleIdList": ["10.1002/med.21454", "28598559"]}, {"Citation": "Prithwiraj D., Florence B.-B., Corinne V.-B., Michel B. Cinnamic acid derivatives in tuberculosis, malaria and cardiovascular diseases\u2014A review. Curr. Org. Chem. 2012;16:747\u2013768. doi: 10.2174/138527212799958020.", "ArticleIdList": ["10.2174/138527212799958020"]}, {"Citation": "Kanaani J., Ginsburg H. Effects of cinnamic acid derivatives on in vitro growth of Plasmodium falciparum and on the permeability of the membrane of malaria-infected erythrocytes. Antimicrob. Agents Chemother. 1992;36:1102\u20131108. doi: 10.1128/AAC.36.5.1102.", "ArticleIdList": ["10.1128/AAC.36.5.1102", "PMC188843", "1510401"]}, {"Citation": "Seck R., Mansaly M., Gassama A., Cav\u00e9 C., Cojean S. Synthesis and antimalarial activity of cinnamic acid derivatives. Eur. J. Biomed. Pharm. Sci. 2019;6:450\u2013454."}, {"Citation": "Wiesner J., Mitsch A., Wi\u00dfner P., Jomaa H., Schlitzer M. Structure\u2013activity relationships of novel anti-malarial agents. Part 2: Cinnamic acid derivatives. Bioorg. Med. Chem. Lett. 2001;11:423\u2013424. doi: 10.1016/S0960-894X(00)00684-3.", "ArticleIdList": ["10.1016/S0960-894X(00)00684-3", "11212126"]}, {"Citation": "Bouarab-Chibane L., Forquet V., Lanteri P., Clement Y., Leonard-Akkari L., Oulahal N., Degraeve P., Bordes C. Antibacterial properties of polyphenols: Characterization and qsar (quantitative structure-activity relationship) models. Front. Microbiol. 2019;10:829. doi: 10.3389/fmicb.2019.00829.", "ArticleIdList": ["10.3389/fmicb.2019.00829", "PMC6482321", "31057527"]}, {"Citation": "Cai R. Antibacterial activity and mechanism of cinnamic acid and chlorogenic acid against Alicyclobacillus acidoterrestris vegetative cells in apple juice. Int. J. Food Sci. Tech. 2019;54:1697\u20131705. doi: 10.1111/ijfs.14051.", "ArticleIdList": ["10.1111/ijfs.14051"]}, {"Citation": "Vasconcelos N.G., Croda J., Simionatto S. Antibacterial mechanisms of cinnamon and its constituents: A review. Microb. Pathog. 2018;120:198\u2013203. doi: 10.1016/j.micpath.2018.04.036.", "ArticleIdList": ["10.1016/j.micpath.2018.04.036", "29702210"]}, {"Citation": "Anantharaju P.G., Reddy D.B., Padukudru M.A., Chitturi C.M.K., Vimalambike M.G., Madhunapantula S.V. Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of histone deacetylases (hdac) PLoS ONE. 2017;12:e0186208. doi: 10.1371/journal.pone.0186208.", "ArticleIdList": ["10.1371/journal.pone.0186208", "PMC5708809", "29190639"]}, {"Citation": "Hunke M., Martinez W., Kashyap A., Bokoskie T., Pattabiraman M., Chandra S. Antineoplastic actions of cinnamic acids and their dimers in breast cancer cells: A comparative study. Anticancer Res. 2018;38:4469\u20134474. doi: 10.21873/anticanres.12749.", "ArticleIdList": ["10.21873/anticanres.12749", "30061211"]}, {"Citation": "Ka H., Park H.J., Jung H.J., Choi J.W., Cho K.S., Ha J., Lee K.T. Cinnamaldehyde induces apoptosis by ros-mediated mitochondrial permeability transition in human promyelocytic leukemia hl-60 cells. Cancer Lett. 2003;196:143\u2013152. doi: 10.1016/S0304-3835(03)00238-6.", "ArticleIdList": ["10.1016/S0304-3835(03)00238-6", "12860272"]}, {"Citation": "NavaneethaKrishnan S., Rosales J.L., Lee K.Y. ROS-mediated cancer cell killing through dietary phytochemicals. Oxid. Med. Cell Longev. 2019;2019:9051542. doi: 10.1155/2019/9051542.", "ArticleIdList": ["10.1155/2019/9051542", "PMC6536988", "31217841"]}, {"Citation": "Niero E.L., Machado-Santelli G.M. Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J. Exp. Clin. Cancer Res. 2013;32:31. doi: 10.1186/1756-9966-32-31.", "ArticleIdList": ["10.1186/1756-9966-32-31", "PMC3667113", "23701745"]}, {"Citation": "Qi G., Chen J., Shi C., Wang Y., Mi S., Shao W., Yu X., Ma Y., Ling J., Huang J. Cinnamic acid (cinn) induces apoptosis and proliferation in human nasopharyngeal carcinoma cells. Cell Physiol. Biochem. 2016;40:589\u2013596. doi: 10.1159/000452572.", "ArticleIdList": ["10.1159/000452572", "27889776"]}, {"Citation": "Zhu B., Shang B., Li Y., Zhen Y. Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice. Mol. Med. Rep. 2016;13:4159\u20134166. doi: 10.3892/mmr.2016.5041.", "ArticleIdList": ["10.3892/mmr.2016.5041", "PMC4838168", "27035417"]}, {"Citation": "Hemaiswarya S., Doble M. Synergistic interaction of phenylpropanoids with antibiotics against bacteria. J. Med. Microbiol. 2010;59:1469\u20131476. doi: 10.1099/jmm.0.022426-0.", "ArticleIdList": ["10.1099/jmm.0.022426-0", "20724513"]}, {"Citation": "Peperidou A., Pontiki E., Hadjipavlou-Litina D., Voulgari E., Avgoustakis K. Multifunctional cinnamic acid derivatives. Molecules. 2017;22:1247. doi: 10.3390/molecules22081247.", "ArticleIdList": ["10.3390/molecules22081247", "PMC6152057", "28757554"]}, {"Citation": "Pontiki E., Peperidou A., Fotopoulos I., Hadjipavlou-Litina D. Cinnamate hybrids: A unique family of compounds with multiple biological activities. Curr. Pharm. Biotechnol. 2018;19:1019\u20131048. doi: 10.2174/1389201019666181112102702.", "ArticleIdList": ["10.2174/1389201019666181112102702", "30417783"]}, {"Citation": "Zofou D., Tene M., Tane P., Titanji V.P. Antimalarial drug interactions of compounds isolated from Kigelia africana (bignoniaceae) and their synergism with artemether, against the multidrug-resistant w2mef plasmodium falciparum strain. Parasitol. Res. 2012;110:539\u2013544. doi: 10.1007/s00436-011-2519-9.", "ArticleIdList": ["10.1007/s00436-011-2519-9", "21814840"]}, {"Citation": "Marchetti R.V., Lehane A.M., Shafik S.H., Winterberg M., Martin R.E., Kirk K. A lactate and formate transporter in the intraerythrocytic malaria parasite, Plasmodium falciparum. Nat. Commun. 2015;6:6721. doi: 10.1038/ncomms7721.", "ArticleIdList": ["10.1038/ncomms7721", "25823844"]}, {"Citation": "Zolg J.W., Alexander J.M., Scaife J.G., Beaudoin R.L. The accumulation of lactic acid and its influence on the growth of Plasmodium falciparum in synchronized cultures. In Vitro. 1984;20:205\u2013215. doi: 10.1007/BF02618189.", "ArticleIdList": ["10.1007/BF02618189", "6370836"]}, {"Citation": "Ginsburg H., Krugliak M., Eidelman O., Ioav Cabantchik Z. New permeability pathways induced in membranes of Plasmodium falciparum infected erythrocytes. Mol. Biochem. Parasitol. 1983;8:177\u2013190. doi: 10.1016/0166-6851(83)90008-7.", "ArticleIdList": ["10.1016/0166-6851(83)90008-7", "6348537"]}, {"Citation": "Kirk K., Lehane A.M. Membrane transport in the malaria parasite and its host erythrocyte. Biochem. J. 2014;457:1\u201318. doi: 10.1042/BJ20131007.", "ArticleIdList": ["10.1042/BJ20131007", "24325549"]}, {"Citation": "Sherman I.W. Reflections on a century of malaria biochemistry. Adv. Parasitol. 2009;67:1\u2013402.", "ArticleIdList": ["18940418"]}, {"Citation": "Staines H.M., Ellory J.C., Chibale K. The new permeability pathways: Targets and selective routes for the development of new antimalarial agents. Comb. Chem. High Throughput Screen. 2005;8:81\u201388. doi: 10.2174/1386207053328138.", "ArticleIdList": ["10.2174/1386207053328138", "15720199"]}, {"Citation": "Masic A., Valencia Hernandez A.M., Hazra S., Glaser J., Holzgrabe U., Hazra B., Schurigt U. Cinnamic acid bornyl ester derivatives from Valeriana wallichii exhibit antileishmanial in vivo activity in Leishmania major-infected BALB/c mice. PLoS ONE. 2015;10:e0142386. doi: 10.1371/journal.pone.0142386.", "ArticleIdList": ["10.1371/journal.pone.0142386", "PMC4640567", "26554591"]}, {"Citation": "Santos A., Fialho S.N., Medeiros D.S.S., Garay A.F.G., Diaz J.A.R., Gomez M.C.V., Teles C.B.G., Calderon L.A. Antiprotozoal action of synthetic cinnamic acid analogs. Rev. Soc. Bras. Med. Trop. 2018;51:849\u2013853. doi: 10.1590/0037-8682-0499-2017.", "ArticleIdList": ["10.1590/0037-8682-0499-2017", "30517542"]}, {"Citation": "Silveira G.R., Campelo K.A., Lima G.R.S., Carvalho L.P., Samarao S.S., Vieira-da-Motta O., Mathias L., Matos C.R.R., Vieira I.J.C., Melo E.J.T., et al. In vitro anti-Toxoplasma gondii and antimicrobial activity of amides derived from cinnamic acid. Molecules. 2018;23:774. doi: 10.3390/molecules23040774.", "ArticleIdList": ["10.3390/molecules23040774", "PMC6017938", "29597255"]}, {"Citation": "P\u00e9rez B., Teixeira C., Gut J., Rosenthal P.J., Gomes J.R., Gomes P. Cinnamic acid/chloroquinoline conjugates as potent agents against chloroquine-resistant Plasmodium falciparum. ChemMedChem. 2012;7:1537\u20131540. doi: 10.1002/cmdc.201200257.", "ArticleIdList": ["10.1002/cmdc.201200257", "22753234"]}, {"Citation": "P\u00e9rez B.C., Teixeira C., Albuquerque I.S., Gut J., Rosenthal P.J., Gomes J.R.B., Prud\u00eancio M., Gomes P. N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads. J. Med. Chem. 2013;56:556\u2013567. doi: 10.1021/jm301654b.", "ArticleIdList": ["10.1021/jm301654b", "23273038"]}, {"Citation": "P\u00e9rez B.C., Teixeira C., Figueiras M., Gut J., Rosenthal P.J., Gomes J.R.B., Gomes P. Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials. Eur. J. Med. Chem. 2012;54:887\u2013899. doi: 10.1016/j.ejmech.2012.05.022.", "ArticleIdList": ["10.1016/j.ejmech.2012.05.022", "22683112"]}, {"Citation": "Dechy-Cabaret O., Benoit-Vical F., Robert A., Meunier B. Preparation and antimalarial activities of \u201ctrioxaquines\u201d, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem. 2000;1:281\u2013283. doi: 10.1002/1439-7633(20001117)1:4<281::AID-CBIC281>3.0.CO;2-W.", "ArticleIdList": ["10.1002/1439-7633(20001117)1:4<281::AID-CBIC281>3.0.CO;2-W", "11828420"]}, {"Citation": "Meunier B. Hybrid molecules with a dual mode of action: Dream or reality? Acc. Chem. Res. 2008;41:69\u201377. doi: 10.1021/ar7000843.", "ArticleIdList": ["10.1021/ar7000843", "17665872"]}, {"Citation": "Nqoro X., Tobeka N., Aderibigbe B.A. Quinoline-based hybrid compounds with antimalarial activity. Molecules. 2017;22:2268. doi: 10.3390/molecules22122268.", "ArticleIdList": ["10.3390/molecules22122268", "PMC6149725", "29257067"]}, {"Citation": "Moles E., Galiano S., Gomes A., Quiliano M., Teixeira C., Aldana I., Gomes P., Fernandez-Busquets X. Immunopegliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model. Biomaterials. 2017;145:178\u2013191. doi: 10.1016/j.biomaterials.2017.08.020.", "ArticleIdList": ["10.1016/j.biomaterials.2017.08.020", "28869864"]}, {"Citation": "Vale N., Moreira R., Gomes P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 2009;44:937\u2013953. doi: 10.1016/j.ejmech.2008.08.011.", "ArticleIdList": ["10.1016/j.ejmech.2008.08.011", "18930565"]}, {"Citation": "P\u00e9rez B., Teixeira C., Albuquerque I.S., Gut J., Rosenthal P.J., Prud\u00eancio M., Gomes P. Primacins, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity. MedChemComm. 2012;3:1170\u20131172. doi: 10.1039/c2md20113e.", "ArticleIdList": ["10.1039/c2md20113e"]}, {"Citation": "Beus M., Fontinha D., Held J., Rajic Z., Uzelac L., Kralj M., Prud\u00eancio M., Zorc B. Primaquine and chloroquine fumardiamides as promising antiplasmodial agents. Molecules. 2019;24:2812. doi: 10.3390/molecules24152812.", "ArticleIdList": ["10.3390/molecules24152812", "PMC6695747", "31374989"]}, {"Citation": "Teixeira C., Vale N., P\u00e9rez B., Gomes A., Gomes J.R., Gomes P. \u201cRecycling\u201d classical drugs for malaria. Chem. Rev. 2014;114:11164\u201311220. doi: 10.1021/cr500123g.", "ArticleIdList": ["10.1021/cr500123g", "25329927"]}, {"Citation": "Gomes A., P\u00e9rez B., Albuquerque I., Machado M., Prud\u00eancio M., Nogueira F., Teixeira C., Gomes P. N-cinnamoylation of antimalarial classics: Quinacrine analogues with decreased toxicity and dual-stage activity. ChemMedChem. 2014;9:305\u2013310. doi: 10.1002/cmdc.201300459.", "ArticleIdList": ["10.1002/cmdc.201300459", "24474655"]}, {"Citation": "P\u00e9rez B., Teixeira C., Gomes A.S., Albuquerque I.S., Gut J., Rosenthal P.J., Prud\u00eancio M., Gomes P. In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites. Bioorg. Med. Chem. Lett. 2013;23:610\u2013613. doi: 10.1016/j.bmcl.2012.12.032.", "ArticleIdList": ["10.1016/j.bmcl.2012.12.032", "23290049"]}, {"Citation": "Gomes A., Machado M., Lobo L., Nogueira F., Prud\u00eancio M., Teixeira C., Gomes P. N-cinnamoylation of antimalarial classics: Effects of using acyl groups other than cinnamoyl toward dual-stage antimalarials. ChemMedChem. 2015;10:1344\u20131349. doi: 10.1002/cmdc.201500164.", "ArticleIdList": ["10.1002/cmdc.201500164", "26038181"]}, {"Citation": "Wiesner J., Kettler K., Jomaa H., Schlitzer M. Structure\u2013activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides. Bioorg. Med. Chem. Lett. 2002;12:543\u2013545. doi: 10.1016/S0960-894X(01)00798-3.", "ArticleIdList": ["10.1016/S0960-894X(01)00798-3", "11844668"]}, {"Citation": "Calderwood D.J., Johnston D.N., Munschauer R., Rafferty P. Pyrrolo [2,3-d]pyrimidines containing diverse n-7 substituents as potent inhibitors of lck. Bioorg. Med. Chem. Lett. 2002;12:1683\u20131686. doi: 10.1016/S0960-894X(02)00195-6.", "ArticleIdList": ["10.1016/S0960-894X(02)00195-6", "12039590"]}, {"Citation": "Verbaanderd C., Maes H., Schaaf M.B., Sukhatme V.P., Pantziarka P., Sukhatme V., Agostinis P., Bouche G. Repurposing drugs in oncology (redo)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancer. 2017;11:781. doi: 10.3332/ecancer.2017.781.", "ArticleIdList": ["10.3332/ecancer.2017.781", "PMC5718030", "29225688"]}, {"Citation": "Oien D.B., Pathoulas C.L., Ray U., Thirusangu P., Kalogera E., Shridhar V. Repurposing quinacrine for treatment-refractory cancer. Semin. Cancer Biol. 2019 doi: 10.1016/j.semcancer.2019.09.021. in press.", "ArticleIdList": ["10.1016/j.semcancer.2019.09.021", "31562955"]}, {"Citation": "Yan H., Bian A., Gao X., Li H., Chen Z., Liu X. Novel applications for an established antimalarial drug: Tumoricidal activity of quinacrine. Future Oncol. 2018;14:1511\u20131520. doi: 10.2217/fon-2017-0728.", "ArticleIdList": ["10.2217/fon-2017-0728", "29380639"]}, {"Citation": "P\u00e9rez B.C., Fernandes I., Mateus N., Teixeira C., Gomes P. Recycling antimalarial leads for cancer: Antiproliferative properties of n-cinnamoyl chloroquine analogues. Bioorg. Med. Chem. Lett. 2013;23:6769\u20136772. doi: 10.1016/j.bmcl.2013.10.025.", "ArticleIdList": ["10.1016/j.bmcl.2013.10.025", "24184076"]}, {"Citation": "Gomes A., Fernandes I., Teixeira C., Mateus N., Sottomayor M.J., Gomes P. A quinacrine analogue selective against gastric cancer cells: Insight from biochemical and biophysical studies. ChemMedChem. 2016;11:2703\u20132712. doi: 10.1002/cmdc.201600477.", "ArticleIdList": ["10.1002/cmdc.201600477", "27863116"]}, {"Citation": "Pavic K., Perkovic I., Gilja P., Kozlina F., Ester K., Kralj M., Schols D., Hadjipavlou-Litina D., Pontiki E., Zorc B. Design, synthesis and biological evaluation of novel primaquine-cinnamic acid conjugates of the amide and acylsemicarbazide type. Molecules. 2016;21:1629. doi: 10.3390/molecules21121629.", "ArticleIdList": ["10.3390/molecules21121629", "PMC6273687", "27916811"]}, {"Citation": "Mabeta P., Pavic K., Zorc B. Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on mcf-7 cells. Acta Pharm. 2018;68:337\u2013348. doi: 10.2478/acph-2018-0021.", "ArticleIdList": ["10.2478/acph-2018-0021", "31259699"]}, {"Citation": "Crespo-Ortiz M.P., Wei M.Q. Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol. 2012;2012:247597. doi: 10.1155/2012/247597.", "ArticleIdList": ["10.1155/2012/247597", "PMC3228295", "22174561"]}, {"Citation": "Slez\u00e1kov\u00e1 S.R.J. Anticancer activity of artemisinin and its derivatives. Anticancer Res. 2017;37:5995\u20136003.", "ArticleIdList": ["29061778"]}, {"Citation": "Xu C.-C., Deng T., Fan M.-L., Lv W.-B., Liu J.-H., Yu B.-Y. Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives. Eur. J. Med. Chem. 2016;107:192\u2013203. doi: 10.1016/j.ejmech.2015.11.003.", "ArticleIdList": ["10.1016/j.ejmech.2015.11.003", "26595184"]}, {"Citation": "Uniprotkb\u2014c3veh9.  [(accessed on 13 November 2019)]; Available online:  https://www.Uniprot.Org/uniprot/c3veh9."}, {"Citation": "P\u00e9rez B., Antunes S., Goncalves L.M., Domingos A., Gomes J.R., Gomes P., Teixeira C. Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: In vitro evaluation, homology modeling and molecular docking studies. J. Comput. Aided Mol. Des. 2013;27:823\u2013835. doi: 10.1007/s10822-013-9682-2.", "ArticleIdList": ["10.1007/s10822-013-9682-2", "24129820"]}, {"Citation": "Vale-Costa S., Costa-Gouveia J., P\u00e9rez B., Silva T., Teixeira C., Gomes P., Gomes M.S. N-cinnamoylated aminoquinolines as promising antileishmanial agents. Antimicrob. Agents Chemother. 2013;57:5112\u20135115. doi: 10.1128/AAC.00557-13.", "ArticleIdList": ["10.1128/AAC.00557-13", "PMC3811464", "23917315"]}, {"Citation": "Loiseau P.M., Cojean S., Schrevel J. Sitamaquine as a putative antileishmanial drug candidate: From the mechanism of action to the risk of drug resistance. Parasite. 2011;18:115\u2013119. doi: 10.1051/parasite/2011182115.", "ArticleIdList": ["10.1051/parasite/2011182115", "PMC3671420", "21678786"]}, {"Citation": "Yardley V., Gamarro F., Croft S.L. Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine. Antimicrob. Agents Chemother. 2010;54:5356\u20135358. doi: 10.1128/AAC.00985-10.", "ArticleIdList": ["10.1128/AAC.00985-10", "PMC2981226", "20837750"]}, {"Citation": "Pena A.C., P\u00e9rez B., Teixeira C., Gomes P., Figueiredo L.M. In vitro activity of cinnamic acid conjugates of classic antimalarials against Trypanossoma brucei brucei. bioRxiv. 2020 Manuscript in preparation."}, {"Citation": "Gomes A., Ferraz R., Ficker L., Collins M.S., Prud\u00eancio C., Cushion M.T., Teixeira C., Gomes P. Chloroquine analogues as leads against pneumocystis lung pathogens. Antimicrob. Agents Chemother. 2018;62:e00983-18. doi: 10.1128/AAC.00983-18.", "ArticleIdList": ["10.1128/AAC.00983-18", "PMC6201078", "30201816"]}, {"Citation": "Benfield T., Atzori C., Miller R.F., Helweg-Larsen J. Second-line salvage treatment of aids-associated Pneumocystis jirovecii pneumonia: A case series and systematic review. J. Acquir. Immune Defic. Syndr. 2008;48:63\u201367. doi: 10.1097/QAI.0b013e31816de84d.", "ArticleIdList": ["10.1097/QAI.0b013e31816de84d", "18360286"]}, {"Citation": "Porollo A., Meller J., Joshi Y., Jaiswal V., Smulian A.G., Cushion M.T. Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome. Curr. Drug Targets. 2012;13:1575\u20131585. doi: 10.2174/138945012803530107.", "ArticleIdList": ["10.2174/138945012803530107", "PMC3907186", "22934582"]}, {"Citation": "Egorova K.S., Gordeev E.G., Ananikov V.P. Biological activity of ionic liquids and their application in pharmaceutics and medicine. Chem. Rev. 2017;117:7132\u20137189. doi: 10.1021/acs.chemrev.6b00562.", "ArticleIdList": ["10.1021/acs.chemrev.6b00562", "28125212"]}, {"Citation": "Ferraz R., Teixeira C., Gomes P., Prud\u00eancio C. Ionic Liquid Devices. The Royal Society of Chemistry; London, UK: 2018. Chapter 16\u2014Bioactivity of ionic liquids; pp. 404\u2013422."}, {"Citation": "Shamshina J.L., Berton P., Wang H., Zhou X., Gurau G., Rogers R.D. Green Techniques for Organic Synthesis and Medicinal Chemistry. 2nd ed. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2018. Chapter 20\u2013Ionic liquids in pharmaceutical industry; pp. 539\u2013577."}, {"Citation": "Shamshina J.L., Rogers R.D. Overcoming the problems of solid state drug formulations with ionic liquids. Ther. Delivery. 2014;5:489\u2013491. doi: 10.4155/tde.14.28.", "ArticleIdList": ["10.4155/tde.14.28", "24998266"]}, {"Citation": "Ferraz R., Noronha J., Murtinheira F., Nogueira F., Machado M., Prud\u00eancio M., Parapini S., D\u2019Alessandro S., Teixeira C., Gomes A., et al. Primaquine-based ionic liquids as a novel class of antimalarial hits. RSC Adv. 2016;6:56134\u201356138. doi: 10.1039/C6RA10759A.", "ArticleIdList": ["10.1039/C6RA10759A"]}, {"Citation": "Ferraz R., Pinheiro M., Gomes A., Teixeira C., Prud\u00eancio C., Reis S., Gomes P. Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models. Bioorg. Med. Chem. Lett. 2017;27:4190\u20134193. doi: 10.1016/j.bmcl.2017.07.006.", "ArticleIdList": ["10.1016/j.bmcl.2017.07.006", "28733082"]}, {"Citation": "Silva A.T., Fontinha D., Lobo L., Oliveira I., Nogueira F., Prud\u00eancio M., Marques E.F.M., Teixeira C., Ferraz R., Gomes P. Combination of chloroquine with natural carboxylic acids: From poorly active cinnamates to potent antimalarial surface-active ionic liquids derived from fatty acids. J. Mol. Liq. 2020 Manuscript in preparation."}, {"Citation": "Santos M.M., Raposo L.R., Carrera G., Costa A., Dionisio M., Baptista P.V., Fernandes A.R., Branco L.C. Ionic liquids and salts from ibuprofen as promising innovative formulations of an old drug. ChemMedChem. 2019;14:907\u2013911. doi: 10.1002/cmdc.201900040.", "ArticleIdList": ["10.1002/cmdc.201900040", "30735308"]}, {"Citation": "Wu H., Deng Z., Zhou B., Qi M., Hong M., Ren G. Improved transdermal permeability of ibuprofen by ionic liquid technology: Correlation between counterion structure and the physicochemical and biological properties. J. Mol. Liq. 2019;283:399\u2013409. doi: 10.1016/j.molliq.2019.03.046.", "ArticleIdList": ["10.1016/j.molliq.2019.03.046"]}, {"Citation": "Bento C. Master\u2019s Thesis. Universidade do Porto; Porto, Portugal: Sep, 2019. Evaluation of the Effects of Selected Ionic Liquids Against Mycobacterium avium."}, {"Citation": "Park H.J., Prausnitz M.R. Lidocaine-ibuprofen ionic liquid for dermal anesthesia. AIChE J. 2015;61:2732\u20132738. doi: 10.1002/aic.14941.", "ArticleIdList": ["10.1002/aic.14941"]}, {"Citation": "Sidat Z., Marimuthu T., Kumar P., du Toit L.C., Kondiah P.P.D., Choonara Y.E., Pillay V. Ionic liquids as potential and synergistic permeation enhancers for transdermal drug delivery. Pharmaceutics. 2019;11:96. doi: 10.3390/pharmaceutics11020096.", "ArticleIdList": ["10.3390/pharmaceutics11020096", "PMC6409523", "30813375"]}, {"Citation": "No Time to Wait: Securing the Future from Drug-Resistant Infections.  [(accessed on 12 November 2019)]; Available online:  https://www.Who.Int/docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.Pdf?Sfvrsn=5b424d7_6."}]}], "History": [{"Year": "2019", "Month": "11", "Day": "28"}, {"Year": "2019", "Month": "12", "Day": "13"}, {"Year": "2019", "Month": "12", "Day": "20"}, {"Year": "2019", "Month": "12", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["31878190", "PMC6982862", "10.3390/molecules25010066", "molecules25010066"]}}]}